The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Yun, Cai-Hong, Mengwasser, Kristen E., Toms, Angela V., Woo, Michele S., Greulich, Heidi, Wong, Kwok-Kin, Meyerson, Matthew, Eck, Michael J.·2008·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.0709662105

Cited by (1,002)

Items 1,001–1,002 of 1,002

  1. Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
    Frega, Stefano, Lorenzi, Martina, Fassan, Matteo, Indraccolo, Stefano, Calabrese, Fiorella, Favaretto, Adolfo, Bonanno, Laura, Polo, Valentina, Zago, Giulia, Lunardi, Francesca et al. · 2017 · Oncotarget
  2. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
    2015 · Europe PMC (PubMed Central)